EVALUATION OF PATIENTS' NEEDS REGARDING INFORMATION ON ANTICANCER TREATMENTS DELIVERED TO OUR HEALTH INSTITUTION AS PART OF A THERAPEUTIC EDUCATION PROJECT
DI-082
EFFICACY IN CLINICAL PRACTICE OF NEW DIRECT ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C VIRUS
DI-054
ARE PATIENTS ADHERENT TO THALIDOMIDE?
DI-053
ADHERENCE TO IMMUNOMODULATORY DRUGS IN PATIENTS WITH MULTIPLE MYELOMA
DI-037
IMPACT OF SPANISH PHARMACOVIGILANCE LEGISLATION ON SUSPECTED ADVERSE DRUG REACTIONS REPORTED BY THE HOSPITAL PHARMACY SERVICE
DI-036
METRONOMIC CHEMOTHERAPY WITH ORAL VINORELBINE: EPIDEMIOLOGICAL ANALYSIS AND ECONOMIC EVALUATION
DI-096
REFRACTORY LANCE--ADAMS SYNDROME:: PHARMACOTHERAPY MANAGEMENT AND IIATROGENIIC COMPLIICATIIONS
DI-093
OFF-LABEL DRUG USE IN ONCO-HAEMATOLOGY SETTING
DI-088
THE SWITCH FROM ORIGINATOR TO BIOSIMILAR GROWTH HORMONE: PATIENTS' EXPERIENCES
DI-079
THERAPEUTIC MANAGEMENT OF LEAD POISONING: SATURNISM
DI-077
A PHARMACEUTICAL CARE PROGRAM TO IMPROVE PAIN MANAGEMENT IN PATIENTS WITH ADVANCED PROSTATE CANCER
DI-076
CLINICAL EXPERIENCE WITH DARUNAVIR PLUS COBICISTAT COMBINATION IN HUMAN IMMUNODEFICIENCY VIRUS TREATMENT
DI-074
EFFICACY AND SAFETY OF TRASTUZUMAB IN METASTATIC GASTRIC CANCER
DI-073
MEDICINE INFORMATION CLINICAL PHARMACY SERVICES: QUANTIFICATION AND CHARACTERISATION OF ENQUIRIES FROM GPS AND INVESTIGATION OF THEIR AWARENESS, EXPERIENCES AND VIEWS
DI-069
CUTANEOUS TOLERANCE TO LONG TERM ANAKINRA THERAPY : REPORT OF A 9 YEAR EXPERIENCE AND REVIEW OF FRENCH PHARMACOVIGILANCE
